Clinical trials
Recruiting Hemophilia B trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Pfizer | 2 |
| Peking University People's Hospital | 1 |
| Shanghai RAAS Blood Products Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia B | 8 |
| Hemophilia A | 5 |
| Hemostatic Disorders | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Disseminated Intravascular Coagulation | 1 |
| Factor VII Deficiency | 1 |
| Hemoglobinuria, Paroxysmal | 1 |
| Hemorrhage | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.